THERABIOGEN, INC. (TRAB)

[mastaflash]

Charles B. Hensley, Ph.D. Chairman and Chief Executive Officer



Prior to forming PRB Pharmaceuticals, Dr. Hensley was president of Zengen, a California biotech company specializing in anti-inflammatory medications. Dr. Hensley was a founder and Chief of Research and Scientific Affairs at Gel Tech, LLC, a joint venture between BioDelivery Technologies, Inc., and Gum Tech International, a NASDAQ publicly traded company. While at BioDelivery Technologies, Dr. Hensley invented Zicam® cold remedy, currently the most effective OTC remedy for the common cold on the market. From 1997 to 1999, Dr. Hensley served as Chairman of BioDelivery Technologies, Inc., which was acquired by Zengen in March 2000. From 1994 to 1997, Dr. Hensley served as Chairman of Biotem Cytotechnologies. Dr. Hensley received his Bachelor of Science degree in pre-med/Zoology from the University of Oklahoma and received his Ph.D. in Physiology and Biophysics at the University of Southern California School of Medicine. He completed his postdoctoral fellowship at the University of Southern California School of Medicine where he specialized in the mechanism of pharmaceutical drugs on regulation of gene expression

http://www.prbpharmaceuticals.com/prb_about.php?i_id=3